News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

Positive FDA Meeting for Abuse Deterrent Fentanyl Patch

The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth

Candy and Other Food Treats or Tricks

A Time of Reckoning: Halloween, Days of the Dead, and Election Day

Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?

© 2025 MJH Life Sciences^®

All rights reserved.